Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine

Hiroyuki Takeda(St. Marianna University School of Medicine), Chifumi Kitanaka(Yamagata University), Takashi Yoshioka, Shuhei Suzuki(Yamagata University), Hikaru Watarai(Yamagata University), Masashi Okada(Yamagata University), Kenta Kuramoto(Northwestern University), Hirotsugu Sakaki(Yamagata University), Shizuka Seino(Yamagata University), Tomomi Sanomachi(Yamagata University)
Anticancer Research
December 1, 2016
Cited by 35


Related Papers